14.56
+0.02
+(0.14%)
At close: January 31 at 4:25:00 PM GMT+1
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
339,323.00
319,037.00
284,111.00
221,912.00
Total Liabilities Net Minority Interest
30,026.00
34,301.00
39,267.00
25,581.00
Total Equity Gross Minority Interest
309,297.00
284,736.00
244,844.00
196,331.00
Total Capitalization
309,297.00
284,736.00
244,844.00
194,365.00
Common Stock Equity
309,297.00
284,736.00
244,844.00
194,365.00
Capital Lease Obligations
12,588.00
14,080.00
17,569.00
11,963.00
Net Tangible Assets
283,203.00
275,502.00
243,056.00
193,945.00
Working Capital
258,384.00
245,293.00
208,623.00
158,785.00
Invested Capital
309,297.00
284,736.00
244,844.00
194,365.00
Tangible Book Value
283,203.00
275,502.00
243,056.00
193,945.00
Total Debt
12,588.00
14,080.00
17,569.00
11,963.00
Share Issued
50,871.39
50,571.39
50,371.39
48,334.67
Ordinary Shares Number
50,871.39
50,571.39
50,371.39
48,334.67
12/31/2020 - 11/4/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CLBIO.ST Corline Biomedical AB
9.42
+1.73%
PCIB.OL PCI Biotech Holding ASA
1.2500
+2.12%
DIABIO.ST Diagonal Bio AB (publ)
0.0189
-5.50%
NYKD.OL Nykode Therapeutics AS
2.6820
+1.98%
OTLC Oncotelic Therapeutics, Inc.
0.0303
+8.21%
ACE.ST Ascelia Pharma AB (publ)
2.9150
+1.92%
CAMX.ST Camurus AB (publ)
596.00
-0.17%
EXPRS2.ST ExpreS2ion Biotech Holding AB (publ)
30.60
+2.00%
NAMS NewAmsterdam Pharma Company N.V.
22.29
+2.39%
APRE Aprea Therapeutics, Inc.
3.9100
+0.51%